Basic Information
| RNALocate ID: | RLID:11001704 |
| RNA Symbol: | hsa-miR-30b-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-30b |
| RNA ID: | miRBase:MIMAT0000420 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23666971 |
| Tissue/Cell Line: | Follicular fluid |
| Method: | Microarray |
| Description: | The TaqMan miRNA Array Card version 3.0, which includes 766 mature miRNAs, detected the presence of miRNAs in both the microvesicles and the supernatant. A total of 120 miRNAs (cycle threshold [Ct] <37) were found in the in microvesicles extracted from 8 mL fresh follicular fluid, and 82 miRNAs (Ct <37) were expressed in 500 uL supernatant (Table 2). Data are collected from Table 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001739 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001740 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001741 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001742 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:01001743 | Plasma membrane vesicle | Ad293 cells | 27165101 |
| RLID:11001694 | Exosome | Human milk | 28688106 |
| RLID:11001695 | Exosome | Plasma | 30154547 |
| RLID:11001696 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001697 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001698 | Exosome | Breast milk | 22211110 |
| RLID:11001699 | Exosome | Brain tissue | 23382797 |
| RLID:11001700 | Exosome | Plasma | 23663360 |
| RLID:11001701 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001702 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001703 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000073 | Exosome | B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000348 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-30b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-36938 |
| MNDR | hsa-miR-30b-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-36939 |
| MNDR | hsa-miR-30b-5p | Glomerulosclerosis | MNDR-E-MI-36940 |
| MNDR | hsa-miR-30b-5p | Oral squamous cell carcinoma | MNDR-E-MI-36941 |
| MNDR | hsa-miR-30b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-36942 |
| MNDR | hsa-miR-30b-5p | Medulloblastoma | MNDR-E-MI-36943 |
| MNDR | hsa-miR-30b-5p | B cell lymphoma of malt type | MNDR-E-MI-36944 |
| MNDR | hsa-miR-30b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-36945 |
| MNDR | hsa-miR-30b-5p | Lymphoma | MNDR-E-MI-36946 |
| MNDR | hsa-miR-30b-5p | Lymphoma non-hodgkin | MNDR-E-MI-36947 |
| MNDR | hsa-miR-30b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-36948 |
| MNDR | hsa-miR-30b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-36949 |
| MNDR | hsa-miR-30b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-36950 |
| MNDR | hsa-miR-30b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-36951 |
| MNDR | hsa-miR-30b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-36952 |
| MNDR | hsa-miR-30b-5p | Niemann-pick disease type c | MNDR-E-MI-36953 |
| MNDR | hsa-miR-30b-5p | Dermatomyositis | MNDR-E-MI-36954 |
| MNDR | hsa-miR-30b-5p | Prostate cancer | MNDR-E-MI-36955 |
| MNDR | hsa-miR-30b-5p | Gastric cancer | MNDR-E-MI-36956 |
| MNDR | hsa-miR-30b-5p | Gastric lymphoma | MNDR-E-MI-36957 |
| MNDR | hsa-miR-30b-5p | Alzheimer disease | MNDR-E-MI-36958 |
| MNDR | hsa-miR-30b-5p | Hypertension | MNDR-E-MI-36959 |
| MNDR | hsa-miR-30b-5p | Intracranial aneurysm | MNDR-E-MI-36960 |
| MNDR | hsa-miR-30b-5p | Esophageal carcinoma | MNDR-E-MI-36961 |
| MNDR | hsa-miR-30b-5p | Dysautonomia familial | MNDR-E-MI-36962 |
| MNDR | hsa-miR-30b-5p | Myotonic dystrophy | MNDR-E-MI-36963 |
| MNDR | hsa-miR-30b-5p | Muscular dystrophy duchenne | MNDR-E-MI-36964 |
| MNDR | hsa-miR-30b-5p | Seizures | MNDR-E-MI-36965 |
| MNDR | hsa-miR-30b-5p | Head and neck cancer | MNDR-E-MI-36966 |
| MNDR | hsa-miR-30b-5p | Leukemia | MNDR-E-MI-36967 |
| MNDR | hsa-miR-30b-5p | Huntington disease | MNDR-E-MI-36968 |
| MNDR | hsa-miR-30b-5p | Chorea | MNDR-E-MI-36969 |
| MNDR | hsa-miR-30b-5p | Cardiovascular disease | MNDR-E-MI-36970 |
| MNDR | hsa-miR-30b-5p | Lung cancer | MNDR-E-MI-36971 |
| MNDR | hsa-miR-30b-5p | Down syndrome | MNDR-E-MI-36972 |
| MNDR | hsa-miR-30b-5p | Parkinson disease | MNDR-E-MI-36973 |
| MNDR | hsa-miR-30b-5p | Niemann-pick disease | MNDR-E-MI-36974 |
| MNDR | hsa-miR-30b-5p | Breast cancer | MNDR-E-MI-36975 |
| MNDR | hsa-miR-30b-5p | Pituitary neoplasms | MNDR-E-MI-36976 |
| MNDR | hsa-miR-30b-5p | Pancreatic cancer | MNDR-E-MI-36977 |
| MNDR | hsa-miR-30b-5p | Melanoma | MNDR-E-MI-36978 |
| MNDR | hsa-miR-30b-5p | Rectum adenocarcinoma | MNDR-E-MI-36979 |
| MNDR | hsa-miR-30b-5p | Nephroblastoma | MNDR-E-MI-36980 |
| MNDR | hsa-miR-30b-5p | Colon cancer | MNDR-E-MI-36981 |
| MNDR | hsa-miR-30b-5p | Colon adenocarcinoma | MNDR-E-MI-36982 |
| MNDR | hsa-miR-30b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-36983 |
| MNDR | hsa-miR-30b-5p | Ovarian cancer | MNDR-E-MI-36984 |
| MNDR | hsa-miR-30b-5p | Acromegaly | MNDR-E-MI-36985 |
| MNDR | hsa-miR-30b-5p | Prostate adenocarcinoma | MNDR-E-MI-36986 |
| MNDR | hsa-miR-30b-5p | Carcinoma ductal breast | MNDR-E-MI-36987 |
| MNDR | hsa-miR-30b-5p | Glioblastoma | MNDR-E-MI-36988 |
| MNDR | hsa-miR-30b-5p | Glioma | MNDR-E-MI-36989 |
| MNDR | hsa-miR-30b-5p | Nemaline myopathy | MNDR-E-MI-36990 |
| MNDR | hsa-miR-30b-5p | Central nervous system lymphoma | MNDR-E-MI-36991 |
| MNDR | hsa-miR-30b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-36992 |
| MNDR | hsa-miR-30b-5p | Temporal lobe epilepsy | MNDR-E-MI-36993 |
| MNDR | hsa-miR-30b-5p | Inclusion body myositis | MNDR-E-MI-36994 |
| MNDR | hsa-miR-30b-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-36995 |
| MNDR | hsa-miR-30b-5p | Gastric adenocarcinoma | MNDR-E-MI-36996 |
| MNDR | hsa-miR-30b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-36997 |
| MNDR | hsa-miR-30b-5p | Pituitary adenoma | MNDR-E-MI-36998 |
| MNDR | hsa-miR-30b-5p | Lung squamous cell carcinoma | MNDR-E-MI-36999 |
| MNDR | hsa-miR-30b-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37000 |
| MNDR | hsa-miR-30b-5p | Lung adenocarcinoma | MNDR-E-MI-37001 |
| MNDR | hsa-miR-30b-5p | Thyroid carcinoma | MNDR-E-MI-37002 |
| MNDR | hsa-miR-30b-5p | Bladder urothelial carcinoma | MNDR-E-MI-37003 |
| MNDR | hsa-miR-30b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-37004 |
| MNDR | hsa-miR-30b-5p | Carcinoma renal cell | MNDR-E-MI-37005 |
| MNDR | hsa-miR-30b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-37006 |
| MNDR | hsa-miR-30b-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37007 |
| MNDR | hsa-miR-30b-5p | Cholangiocarcinoma | MNDR-E-MI-37008 |
| MNDR | hsa-miR-30b-5p | Esophageal cancer | MNDR-E-MI-37009 |
| MNDR | hsa-miR-30b-5p | Liver cirrhosis | MNDR-E-MI-37010 |
| MNDR | hsa-miR-30b-5p | Lung small cell carcinoma | MNDR-E-MI-37011 |
| MNDR | hsa-miR-30b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37012 |
| MNDR | hsa-miR-30b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-37013 |
| MNDR | hsa-miR-30b-5p | Acute t cell leukemia | MNDR-E-MI-37014 |
| MNDR | hsa-miR-30b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-37015 |
| MNDR | hsa-miR-30b-5p | Fibromyalgia | MNDR-E-MI-37016 |
| MNDR | hsa-miR-30b-5p | Breast invasive carcinoma | MNDR-E-MI-37017 |
| MNDR | hsa-miR-30b-5p | Hepatocellular carcinoma | MNDR-E-MI-37018 |
| MNDR | hsa-miR-30b-5p | B-cell lymphoma | MNDR-E-MI-37019 |
| MNDR | hsa-miR-30b-5p | Rheumatoid arthritis | MNDR-E-MI-37020 |
| MNDR | hsa-miR-30b-5p | T-cell leukemia | MNDR-E-MI-37021 |
| MNDR | hsa-miR-30b-5p | Retinoblastoma | MNDR-E-MI-37022 |
| MNDR | hsa-miR-30b-5p | Barrett's adenocarcinoma | MNDR-E-MI-37023 |
| MNDR | hsa-miR-30b-5p | Hodgkin lymphoma | MNDR-E-MI-37024 |
| MNDR | hsa-miR-30b-5p | Burkitt lymphoma | MNDR-E-MI-37025 |
| MNDR | hsa-miR-30b-5p | Tonsil cancer | MNDR-E-MI-37026 |
| MNDR | hsa-miR-30b-5p | Neuromyelitis optica | MNDR-E-MI-37027 |
| MNDR | hsa-miR-30b-5p | Acute myelogenous leukemia | MNDR-E-MI-37028 |
| MNDR | hsa-miR-30b-5p | Colorectal cancer | MNDR-E-MI-37029 |
| MNDR | hsa-miR-30b-5p | Nasopharynx carcinoma | MNDR-E-MI-37030 |
| MNDR | hsa-miR-30b-5p | Ependymoma | MNDR-E-MI-37031 |
| MNDR | hsa-miR-30b-5p | Cardiomegaly | MNDR-E-MI-37032 |
| MNDR | hsa-miR-30b-5p | Nasopharyngeal cancer | MNDR-E-MI-37033 |
| MNDR | hsa-miR-30b-5p | Epstein-barr virus infections | MNDR-E-MI-37034 |
| MNDR | hsa-miR-30b-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37035 |
| MNDR | hsa-miR-30b-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37036 |
| MNDR | hsa-miR-30b-5p | Brain injury chronic | MNDR-E-MI-37037 |
| MNDR | hsa-miR-30b-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37038 |
| MNDR | hsa-miR-30b-5p | Stroke | MNDR-E-MI-37039 |
| MNDR | hsa-miR-30b-5p | Stroke lacunar | MNDR-E-MI-37040 |
| MNDR | hsa-miR-30b-5p | Barrett's carcinogenesis | MNDR-E-MI-37041 |
| MNDR | hsa-miR-30b-5p | Duke C | MNDR-E-MI-37042 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AC254633.1 | Homo sapiens | RR00032111 |
TOP